NCT06698432View on ClinicalTrials.gov

SHR Predicts CMD in Patients with CCS

CompletedOBSERVATIONAL
Enrollment

379

Participants

Timeline

Start Date

June 1, 2015

Primary Completion Date

June 1, 2019

Study Completion Date

June 1, 2019

Conditions
Coronary Microvascular Dysfunction (CMD)Index of Microvascular ResistanceChronic Coronary SyndromePrognosis
Interventions
DEVICE

caIMR

Coronary angiography-derived IMR (caIMR) is a novel and accurate alternative that can enable the assessment of coronary microvascular function easier, and more efficiently and does not require pressure wire or adenosine.

All Listed Sponsors
lead

Ya-Wei Xu

OTHER

NCT06698432 - SHR Predicts CMD in Patients with CCS | Biotech Hunter | Biotech Hunter